Skip to main content
×
×
Home

Dopamine and antipsychotic drug action revisited

  • H. M. Jones (a1) and L. S. Pilowsky (a1)
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Dopamine and antipsychotic drug action revisited
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Dopamine and antipsychotic drug action revisited
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Dopamine and antipsychotic drug action revisited
      Available formats
      ×
Abstract
Copyright
Corresponding author
Dr L. S. Pilowsky, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK. Tel: 0207 848 0531; e-mail: l.Pilowsky@iop.kcl.ac.uk
References
Hide All
Baldessarini, R. J., Katz, B. & Cotton, P. (1984) Dissimilar dosing with high and low potency neuroleptics. American Journal of Psychiatry, 141, 748752.
Bigliani, V., Mulligan, R. S., Acton, P. D., et al (1999) In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123|] epidepride single photon emission tomography (SPET) study. British Journal of Psychiatry, 175, 231238.
Breier, A., Su, T. P., Saunders, R., et al (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proceedings of the National Academy of Sciences of the USA, 94, 25692574.
Bressan, R. A., Erlandsson, K., Jones, H. M., et al (2003) Optimising limbic selective D2/D3 receptor occupancy by risperidone — a1231 epidepride SPET study. Journal of Clinical Psychopharmacology, in press.
Clow, A., Theodoru, A., Jenner, P., et al (1980) Changes in rat striatal dopamine turnover and receptor activity during one year's neuroleptic administration. European Journal of Pharmacology, 63, 135144.
Creese, I., Burt, D. R. & Snyder, S. H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science, 192, 481483.
Farde, L., Wiesel, F. A., Nordstrom, A. L., et al (1989) DI- and D2-Dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology, 99, S28S31.
Farde, L., Wiesel, F. A., Stone-Elander, S., et al (1990) D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [||C] raclopride. Archives of General Psychiatry, 47, 213219.
Gefvert, O., Bergstrom, M., Langstrom, B., et al (1998) Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia. Psychopharmacology (Berlin), 135, 119126.
Johnstone, E. C., Crow, T. J., Frith, C. D., et al (1978) Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet, i, 848851.
Jones, H., Travis, M. J., Mulligan, R. S., et al (2001) In vivo 5HT2a receptor blockade by quetiapine. An R91150 single photon emission tomography study. Psychopharmacology (Berlin), 157, 6066.
Kapur, S. & Seeman, P. (2001) Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis. American Journal of Psychiatry, 158, 360369.
Kapur, S., Zipursky, R. & Remington, G. (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. American Journal of Psychiatry, 156, 286293.
Kapur, S., Zipursky, R., Jones, C., et al (2000a) Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. American Journal of Psychiatry, 157, 514520.
Kapur, S., Zipursky, R., Jones, C., et al (2000b) A positron emission tomography study of quetiapine in schizophrenia. Archives of General Psychiatry, 57, 553559.
Kerwin, R.W. (1994) The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research. British Journal of Psychiatry, 164, 141148.
Konradi, C. & Heckers, S. (2001) Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biological Psychiatry, 50, 729742.
Laruelle, M., Abi-Dargham, A., Van-Dyck, C. H., et al (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences of the USA, 93, 92359240.
Lee, T. & Seeman, P. (1980) Elevation of brain neuroleptic/dopamine receptors in schizophrenia. American Journal of Psychiatry, 137, 191197.
Lidow, M. S., Williams, G.V. & Goldman-Rakic, P. S. (1998) The cerebral cortex: a case for a common site of action of antipsychotics. Trends in Pharmacological Sciences, 19, 136140.
Mackay, A. V., Iversen, L. L., Rossor, M., et al (1982) Increased brain dopamine and dopamine receptors in schizophrenia. Archives of General Psychiatry, 39, 991997.
Martinot, J. L., Peron-Magnan, P., Huret, J. D., et al (1990) Striatal D2 dopaminergic receptors assessed with positron emission tomography and 76Br bromospiperone in untreated schizophrenic patients. American Journal of Psychiatry, 147, 4450.
Melkersson, K. I., Hulting, A. L., Rane, A.J. (2000) Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses. British Journal of Clinical Pharmacology, 51, 317324.
Meltzer, H. Y., Matsubara, S. & Lee, J. C. (1989) The ratios of serotonin and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacology Bulletin, 25, 390397.
Meltzer, H. Y., Park, S. & Kessler, R. (1999) Cognition, schizophrenia and the atypical antipsychotic drugs. Proceedings of the National Academy of Sciences of the USA, 96, 1359113593.
Moore, H., West, A. R. & Grace, A. A. (1999) The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biological Psychiatry, 46, 4055.
Nordstrom, A. L., Farde, L. & Halldin, C. (1993a) High 5HT2 receptor occupancy in clozapine treated patients demonstrated by PET. Psychopharmacology, 110, 365367.
Nordstrom, A. L., Farde, L., Weisel, F. A., et al (1993b) Central D2 dopamine receptor occupancy in relation to antipsychotic drug effects: a double blind PET study of schizophrenic patients. Biological Psychiatry, 33, 227235.
Nyberg, S., Farde, L., Eriksson, L., et al (1993) 5HT2 and D2 dopamine receptor occupancy by risperidone in the living human brain. Psychopharmacology, 110, 265272.
Peroutka, S.J. & Snyder, S. H. (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic and histaminergic receptors to clinical potency. American Journal of Psychiatry, 137, 15181522.
Pilowsky, L. S., Costa, D. C., Ell, P. J., et al (1992) Clozapine, single photon emission tomography and the D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet, 340, 199202.
Pilowsky, L. S., Costa, D. C., Ell, P. J., et al (1993) Antipsychotic medication, D2 dopamine receptor blockade and clinical response — a 1231 IBZM SPET (single photon emission tomography) study. Psychological Medicine, 23, 791799.
Pilowsky, L. S., Costa, D. C., Ell, P. J., et al (1994) D2 dopamine receptor binding in the basal ganglia of antipsychotic free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study. British Journal of Psychiatry, 164, 1626.
Pilowsky, L. S., Mulligan, R. S., Acton, P. D., et al (1997) Limbic selectivity of clozapine. Lancet, 350, 490491.
Reavill, C., Taylor, S. G., Wood, M. D., et al (2000) Pharmacological actions of a novel high-affinity, and selective human dopamine D2 receptor antagonist, SB-277011-A. Journal of Pharmacology and Experimental Therapeutics, 294, 11541165.
Reynolds, G. P. (1983) Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature, 304, 527528.
Seeman, P., Lee, T., Chau-Wong, M., et al (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, 261, 717718.
Stephenson, C. M. E., Bigliani, V., Jones, H. M., et al (2000) Striatal and extra-striatal D2/D3 receptor occupancy by quetiapine in vivo.[123I]-epidepride single photon emission tomography (SPET) study. British Journal of Psychiatry, 177, 408415.
Strange, P. G. (2001) Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacological Reviews, 53, 119133.
Talvik, M., Nordstrom, A. L., Nyberg, S., et al (2001) No support for regional selectivity in clozapine treated patients: a PET study with [||C] raclopride and [||C] FLB 457. American Journal of Psychiatry, 158, 926930.
Taylor, P. & Insel, P. A. (1990) The molecular basis of pharmacologic selectivity. In Principles of Drug Action — The Basis of Pharmacology (eds Pratt, W B. & Taylor, P.), pp. 1102. London: Churchill Livingstone.
Thompson, C. (1994) The use of high-dose antipsychotic medication. British Journal of Psychiatry, 164, 448458.
Travis, M. J., Busatto, G. F., Pilowsky, L. S., et al (1998) 5HT2a receptor blockade in schizophrenic patients treated with risperidone or clozapine, a 1231-5-1-R-91150 single photon emission tomography (SPET) study. British Journal of Psychiatry, 173, 236241.
Van Putten, T. & Marder, S. (1986) Low dose treatment strategies. Journal of Clinical Psychiatry, 47 (suppl.12), 16.
Wolkin, A., Barouche, F., Wolf, A. P., et al (1989) Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. American Journal of Psychiatry, 146, 905908.
Xiberas, X., Martinot, J. L., Mallet, L., et al (2001) Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. British Journal of Psychiatry, 179, 503508.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Dopamine and antipsychotic drug action revisited

  • H. M. Jones (a1) and L. S. Pilowsky (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *